pancreatic cancer and semaglutide Risk of associated with GLP-1 receptor agonist therapy Study: Increased Insulin = Greater

Body-composition or skin-related goals can take longer

Your PlexusDx provider supplies a medical prescription and documentation confirming that GLP-1 therapy addresses a qualifying condition

The lineup includes the Wegovy pill (oral semaglutide, FDA-approved December 2025, launched January 2026, the first FDA-approved oral GLP-1 for weight loss in adults), the Wegovy pen (injectable semaglutide 2.4 mg), Zepbound (tirzepatide via LillyDirect), and Ozempic (off-label for weight loss)

Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and Alzheimer disease Dementia: A randomized clinical trial

You might find the injected form of semaglutide listed under the brand names Ozempic and Wegovy while the tablet form under the brand name Rybelsus, all of which are manufactured by Novo Nordisk